Amcal has suspended StrokeCheck testing after vascular surgeons urged Australians not to use the service
StrokeCheck, a not-for-profit organisation, had partnered with Amcal in an initiative where consumers completed a health questionnaire, underwent an assessment and then either were referred to their own GP or offered lifestyle advice.
“Sigma is aware of recent concerns relating to the StrokeCheck program being offered within Amcal pharmacies,” Sigma said in a statement on Wednesday.
“This program is run by StrokeCheck, an independent charity and not-for-profit organisation, offering services by a qualified GP utilising the consulting suite of the pharmacy.
“Whilst an early review of the program has indicated some positive results for patients, the program has been suspended whilst a further review is undertaken.
“Amcal remains committed to providing accessible care to the community to help entrench a collaborative and proactive approach to improving health management, and to provide referral pathways for patients to re-engage with GPs and the broader healthcare system.”